ProfileGDS4718 / 240043_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 15% 17% 13% 19% 23% 10% 11% 15% 21% 25% 13% 17% 25% 16% 16% 16% 18% 18% 15% 33% 14% 13% 14% 17% 17% 6% 24% 17% 24% 22% 19% 12% 21% 17% 14% 16% 24% 15% 14% 5% 15% 22% 17% 7% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9700815
GSM549102patient 115, normal, homogenized [OPG study]4.0368917
GSM549104patient 119, normal, homogenized [OPG study]3.8746313
GSM549108patient 138, normal, homogenized [OPG study]4.131419
GSM549119patient 077, normal, homogenized [OPG study]4.244723
GSM549133patient 032, cancer, homogenized [OPG study]3.7528810
GSM549139patient 042, cancer, homogenized [OPG study]3.799711
GSM549099patient 107, normal, homogenized [OPG study]3.9707715
GSM549109patient 139, normal, homogenized [OPG study]4.199221
GSM549110patient 046, normal, homogenized [OPG study]4.3369325
GSM549114patient 063, normal, homogenized [OPG study]3.8707613
GSM549122patient 082, normal, homogenized [OPG study]4.0408317
GSM549134patient 033, cancer, homogenized [OPG study]4.3433925
GSM549136patient 036, cancer, homogenized [OPG study]3.9361416
GSM549140patient 044, cancer, homogenized [OPG study]3.9750416
GSM549111patient 047, normal, homogenized [OPG study]3.9893716
GSM549113patient 057, normal, homogenized [OPG study]4.0287418
GSM549132patient 031, cancer, homogenized [OPG study]4.0503818
GSM549137patient 038, cancer, homogenized [OPG study]3.9580915
GSM549142patient 047, cancer, homogenized [OPG study]4.7755833
GSM549100patient 110, normal, homogenized [OPG study]3.9243914
GSM549107patient 135, normal, homogenized [OPG study]3.8576913
GSM549115patient 068, normal, homogenized [OPG study]3.8992814
GSM549116patient 072, normal, homogenized [OPG study]4.0169517
GSM549120patient 078, normal, homogenized [OPG study]4.0404217
GSM549131patient 030, cancer, homogenized [OPG study]3.581226
GSM549118patient 074, normal, homogenized [OPG study]4.2814324
GSM549129patient 027, cancer, homogenized [OPG study]4.0354417
GSM549123patient 088, normal, homogenized [OPG study]4.2712724
GSM549124patient 006, cancer, homogenized [OPG study]4.2721522
GSM549126patient 015, cancer, homogenized [OPG study]4.0906819
GSM549128patient 025, cancer, homogenized [OPG study]3.8301912
GSM549103patient 117, normal, homogenized [OPG study]4.2445421
GSM549117patient 073, normal, homogenized [OPG study]4.0140517
GSM549138patient 041, cancer, homogenized [OPG study]3.9175714
GSM549141patient 045, cancer, homogenized [OPG study]3.929416
GSM549130patient 028, cancer, homogenized [OPG study]4.3013124
GSM549101patient 111, normal, homogenized [OPG study]3.9646815
GSM549105patient 128, normal, homogenized [OPG study]3.926314
GSM549106patient 134, normal, homogenized [OPG study]3.530915
GSM549112patient 048, normal, homogenized [OPG study]3.9760415
GSM549125patient 011, cancer, homogenized [OPG study]4.2316922
GSM549127patient 024, cancer, homogenized [OPG study]4.0302617
GSM549135patient 035, cancer, homogenized [OPG study]3.610467